Cancer Center at Presbyterian

Albuquerque, New Mexico

0 studies enrolling now · 2 studies all time

What they study most

PI3K Pathway Activated Tumors, Tumors With CDK4/6 Pathway Activation

Studies at this site

• LEE011 for Patients With CDK4/6 Pathway Activated Tumors (SIGNATURE) — Completed
• BKM120 for Patients With PI3K-activated Tumors — Completed